Frontier IP Group PLC
Price information
Instrument information
Last 5 trades
| Date | Time | Price | Currency | Volume | Trade Value | Trade type | Trade flag | MIC |
|---|---|---|---|---|---|---|---|---|
| 22.10.20 | 12:32:12 | 66.60 | GBX | 2,000 | 1,332.00 | Off-Book | - | AIMX |
| 22.10.20 | 11:36:39 | 65.25 | GBX | 1,000 | 652.51 | Off-Book | - | AIMX |
| 22.10.20 | 09:44:20 | 65.25 | GBX | 545 | 355.62 | Off-Book | - | AIMX |
| 21.10.20 | 12:24:59 | 65.10 | GBX | 159 | 103.51 | Off-Book | N | AIMX |
| 21.10.20 | 10:15:41 | 65.10 | GBX | 136 | 88.54 | Off-Book | N | AIMX |
Equity Research
from Frontier IP Group PLC
TVG vaccine collaboration with ECO and Pirbright
The Vaccine Group (TVG) has agreed a collaboration with the world-leading Pirbright Institute to develop a vaccine to combat type-1 PRRSV disease, as part of an 18-month development project funded by ECO Animal Health (EAH-LON). PRRSV is a viral disease causing reproductive failure and often fatal r ...
View reportNandi £720k financing; fundraise and progress drives forecast upgrades
Frontier IP has announced it has invested £320k in a £720k convertible loan financing of Nandi Proteins. Nandi Proteins is developing functional proteins for food ingredients aimed at reducing levels of fat, additives and gluten in processed foods addressing important social, health and environmenta ...
View report
Frontier IP participates in £500k PulsiV financing
Frontier IP has announced it has invested £50k in a £500k convertible loan financing of PulsiV. Frontier IP has a 18.9% equity holding in PulsiV, which was last valued at £0.9m on the balance sheet. Whilst the commercial terms of the loan are unknown, it is not expected to have ...
View report
Successful placing of £2.3m to strengthen balance sheet
Frontier IP has successful completed an oversubscribed £2.3m raise with new and existing institutional shareholder support that significantly supports its balance sheet. There was also a retail offering, which will help improve liquidity in the stock. The deal gives Frontier IP the balance ...
View reportProgress of The Vaccine Group’s Covid-19 animal vaccines
The Vaccine Group (TVG; a 17% holding for Frontier IP) has announced positive progress for its novel animal Covid-19 vaccines. Two vaccine candidates of the four in development are now progressing after just eight weeks into animal testing after demonstrating in vitro expression of antigens belon ...
View reportContacts
from Frontier IP Group PLC